These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31454491)

  • 1. Application of IFN-γ/IL-2 FluoroSpot assay for distinguishing active tuberculosis from non-active tuberculosis: A cohort study.
    Zhang L; Wan S; Ye S; Cheng X; Zhang Y; Shi X; Zhou B; Sun X; Liu X
    Clin Chim Acta; 2019 Dec; 499():64-69. PubMed ID: 31454491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study.
    Zhang L; Wan S; Zhou Z; Zhang Y; Liu X
    BMC Infect Dis; 2021 Jul; 21(1):651. PubMed ID: 34225667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of Th1-cell immune responses for distinguishing active tuberculosis from non-active tuberculosis: A case-control study.
    Zhang L; Cheng X; Bian S; Song Y; Li Q; Gao M; Zhang Y; Shi X; Liu X
    PLoS One; 2017; 12(5):e0177850. PubMed ID: 28531231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium tuberculosis latency-associated antigen Rv1733c SLP improves the accuracy of differential diagnosis of active tuberculosis and latent tuberculosis infection.
    Zhang L; Ma H; Wan S; Zhang Y; Gao M; Liu X
    Chin Med J (Engl); 2022 Jan; 135(1):63-69. PubMed ID: 34802023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population.
    Wang S; Diao N; Lu C; Wu J; Gao Y; Chen J; Zhou Z; Huang H; Shao L; Jin J; Weng X; Zhang Y; Zhang W
    PLoS One; 2012; 7(12):e51338. PubMed ID: 23272100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined antigen-specific interferon-γ and interleukin-2 release assay (FluoroSpot) for the diagnosis of Mycobacterium tuberculosis infection.
    Chesov D; Lange C; Daduna F; Crudu V; Preyer R; Ernst M; Kalsdorf B
    PLoS One; 2015; 10(3):e0120006. PubMed ID: 25785445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the characteristics of the enzyme-linked immunospot assay for diagnosis of active tuberculosis in China.
    Wang L; Yu Y; Chen W; Feng J; Wang J; Zhao H; Ma L; Yang B; Ma Y; Dang P
    Clin Vaccine Immunol; 2015 May; 22(5):510-5. PubMed ID: 25739918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
    Sun Q; Wei W; Sha W
    PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An IFN-γ and TNF-α dual release fluorospot assay for diagnosing active tuberculosis.
    Kim JY; Kang YA; Park JH; Cha HH; Jeon NY; Lee SW; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    Clin Microbiol Infect; 2020 Jul; 26(7):928-934. PubMed ID: 31730906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of mean spot sizes of ESAT-6 spot-forming cells and modified tuberculosis-specific antigen/phytohemagglutinin ratio of T-SPOT.TB assay in distinguishing between active tuberculosis and latent tuberculosis infection.
    Luo Y; Tang G; Lin Q; Mao L; Xue Y; Yuan X; Ouyang R; Wu S; Yu J; Zhou Y; Liu W; Hou H; Wang F; Sun Z
    J Infect; 2020 Jul; 81(1):81-89. PubMed ID: 32360883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving T-cell assays for diagnosis of latent TB infection: Confirmation of the potential role of testing Interleukin-2 release in Iranian patients.
    Mamishi S; Pourakbari B; Shams H; Marjani M; Mahmoudi S
    Allergol Immunopathol (Madr); 2016; 44(4):314-21. PubMed ID: 26786720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection.
    Wu J; Wang S; Lu C; Shao L; Gao Y; Zhou Z; Huang H; Zhang Y; Zhang W
    Tuberculosis (Edinb); 2017 Jan; 102():68-75. PubMed ID: 28061954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6 release of Rv0183 antigen-stimulated whole blood is a potential biomarker for active tuberculosis patients.
    Liu Y; Li X; Liu W; Liu Y; Zhong Z; Wang L; Ge S; Zhang J; Xia N
    J Infect; 2018 Apr; 76(4):376-382. PubMed ID: 29174965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TBAg/PHA ratio in T-SPOT.TB assay has high prospective value in the diagnosis of active tuberculosis: a multicenter study in China.
    Liu Y; Yao L; Wang F; Sun Z; Tan Y; Sha W
    Respir Res; 2021 Jun; 22(1):165. PubMed ID: 34074288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of the interferon-γ release assay for tuberculosis infection in patients with Behçet's disease.
    Wu X; Chen P; Wei W; Zhou M; Li C; Liu J; Zhao L; Zhang L; Zhao Y; Zeng X; Liu X; Zheng W
    BMC Infect Dis; 2019 Apr; 19(1):323. PubMed ID: 30987605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High IFN-γ Release and Impaired Capacity of Multi-Cytokine Secretion in IGRA Supernatants Are Associated with Active Tuberculosis.
    Carrère-Kremer S; Rubbo PA; Pisoni A; Bendriss S; Marin G; Peries M; Bolloré K; Terru D; Godreuil S; Bourdin A; Van de Perre P; Tuaillon E
    PLoS One; 2016; 11(9):e0162137. PubMed ID: 27603919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined IFN-γ and IL-2 release assay for detect active pulmonary tuberculosis: a prospective multicentre diagnostic study in China.
    Tan Y; Tan Y; Li J; Hu P; Guan P; Kuang H; Liang Q; Yu Y; Chen Z; Wang Q; Yang Z; AiKeReMu D; Pang Y; Liu J
    J Transl Med; 2021 Jul; 19(1):289. PubMed ID: 34217302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The ratio of tuberculosis-specific antigen to phytohemagglutinin in T-SPOT assay in the diagnosis of active tuberculosis].
    Wang T; Tan YJ; Wu SJ; Huang M; Yin BT; Huang J; Wei N; Wei W; Wang F
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Apr; 42(4):262-267. PubMed ID: 30955283
    [No Abstract]   [Full Text] [Related]  

  • 20. Immuno-Diagnosis of Active Tuberculosis by a Combination of Cytokines/Chemokines Induced by Two Stage-Specific Mycobacterial Antigens: A Pilot Study in a Low TB Incidence Country.
    Dirix V; Collart P; Van Praet A; Hites M; Dauby N; Allard S; Racapé J; Singh M; Locht C; Mascart F; Corbière V
    Front Immunol; 2022; 13():842604. PubMed ID: 35359958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.